ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
124.78
-1.9600
-1.55%
盤後：
124.72
-0.0600
-0.05%
19:53 EST
成交量：
1,335.50萬
成交額：
16.64億
市值：
78.02億
市盈率：
6.84
高：
125.60
開：
124.82
低：
122.94
收：
126.74
52周最高：
132.09
52周最低：
66.66
股本：
6,252.50萬
流通股本：
6,252.50萬
量比：
1.72
換手率：
21.36%
股息：
0.44
股息率：
0.35%
每股收益(TTM):
18.23
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
美國醫療保險優勢計劃增長再度放緩
环球市场播报
·
02/19
和諧健康保險泰州中支被罰69萬，副總被罰15萬
蓝鲸财经
·
02/14
創業慧康新註冊《創業醫療健康數據匯聚系統軟件V6》等2個項目的軟件著作權
中金财经
·
02/14
AMN醫療保健服務公司盤中異動 臨近收盤大幅下挫5.03%報19.34美元
市场透视
·
02/12
Humana公布季度虧損擴大，預計2026年盈利將下降
环球市场播报
·
02/11
Healthcare Services第四季度EPS為0.44美元 高於預期
格隆汇
·
02/11
和諧健康保險泰安中支被罰16萬，涉編制虛假資料
蓝鲸财经
·
02/11
醫療保健板塊動態：市場快訊解讀
投资观察
·
02/11
AMN醫療保健服務公司盤中異動 下午盤股價大漲5.27%
市场透视
·
02/11
貝萊德大中華區陸文傑：中國經濟2026將保持強勁增長，電力和醫療健康確定性更好
华尔街见闻
·
02/09
【投孖展動態】安濟盛生物D輪孖展，孖展額1.3億美元，投資方為Frazier Life Sciences、Venrock Healthcare Capital Partners等
中金财经
·
02/08
2026年度南昌市靈活就業人員繳納醫保指南出爐
南昌发布
·
02/07
一批製造公眾用藥焦慮，引導購買高端醫療保險的賬號被依法處置
市场资讯
·
02/06
【券商聚焦】中信證券：商保有望成為醫療健康產業支付端的核心增量
金吾财讯
·
02/06
醫療保健板塊動態：市場焦點解讀
投资观察
·
02/06
Viemed Healthcare, Inc.盤中異動 股價大漲5.19%報8.52美元
市场透视
·
02/06
Healthcare Triangle, Inc.盤中異動跌6.40% 換手率達47.93%
市场透视
·
02/05
瑞銀——美國醫療保健服務行業周度觀察（附下載）
外资精华观点
·
02/05
復星醫藥：公司直接運營的業務覆蓋製藥、醫療器械及醫學診斷、醫療健康服務
证券日报
·
02/04
一線｜腦機接口商業化轉向：企業正加速從消費場景轉向醫療健康領域
蓝鲸财经
·
02/04
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/XBI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":124.78,"timestamp":1771621200000,"preClose":126.74,"halted":0,"volume":13355039,"hourTrading":{"tag":"盘后","latestPrice":124.72,"preClose":124.78,"latestTime":"19:53 EST","volume":2409541,"amount":300614794.999499,"timestamp":1771635227884,"change":-0.06,"changeRate":-0.000481,"amplitude":0.003927},"delay":0,"changeRate":-0.015464730945242179,"floatShares":62525000,"shares":62525000,"eps":18.23,"marketStatus":"休市中","change":-1.96,"latestTime":"02-20 16:00:00 EST","open":124.82,"high":125.6,"low":122.94,"amount":1663949181.94104,"amplitude":0.020988,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":126.74,"sharesOutstanding":62525000,"nav":124.767021,"aum":7801057975.295,"dividendRate":0.003545,"bidAskSpread":0.000197,"preHourTrading":{"tag":"盘前","latestPrice":125.06,"preClose":126.74,"latestTime":"09:29 EST","volume":16404,"amount":2049493.45056,"timestamp":1771597799999,"change":-1.68,"changeRate":-0.013255,"amplitude":0.009411},"postHourTrading":{"tag":"盘后","latestPrice":124.72,"preClose":124.78,"latestTime":"19:53 EST","volume":2409541,"amount":300614794.999499,"timestamp":1771635227884,"change":-0.06,"changeRate":-0.000481,"amplitude":0.003927},"volumeRatio":1.7184091468222418,"optionData":{"bulkOrders":[{"symbol":"XBI","call":true,"expireDate":1773979200000,"strike":"125.0","timestamp":1771621186384,"price":4.4,"volume":10000,"amount":4400000,"type":"+"},{"symbol":"XBI","call":true,"expireDate":1773979200000,"strike":"135.0","timestamp":1771621186320,"price":0.93,"volume":10000,"amount":930000,"type":"-"}]},"impliedVol":0.3238,"impliedVolPercentile":0.6853},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":62525000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.7184091468222418,"shares":62525000,"dividePrice":0.4423,"high":125.6,"amplitude":0.020988,"preClose":126.74,"low":122.94,"week52Low":66.66,"pbRate":"--","week52High":132.09,"institutionHeld":0.8511,"latestPrice":124.78,"eps":18.23,"divideRate":0.003545,"volume":13355039,"delay":0,"ttmEps":18.23,"open":124.82,"prevYearClose":121.93,"prevWeekClose":122.86,"prevMonthClose":124.75,"prevQuarterClose":121.93,"fiveDayClose":123.18,"twentyDayClose":131.57,"sixtyDayClose":116.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.057833,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612688286","title":"美國醫療保險優勢計劃增長再度放緩","url":"https://stock-news.laohu8.com/highlight/detail?id=2612688286","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612688286?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 23:20","pubTimestamp":1771514400,"startTime":"0","endTime":"0","summary":"美国医疗保险优势计划参保人数同比增长放缓至约3%，在定价和医疗成本压力下，休曼纳（Humana）增加了会员，而联合健康集团和CVS Health旗下的安泰则流失了参保人。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-19/doc-inhnkpth0848747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4581","BK4585","BK4588","XBI","XLV"],"gpt_icon":0},{"id":"2611101921","title":"和諧健康保險泰州中支被罰69萬，副總被罰15萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2611101921","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611101921?lang=zh_tw&edition=fundamental","pubTime":"2026-02-14 23:03","pubTimestamp":1771081408,"startTime":"0","endTime":"0","summary":"蓝鲸新闻2月14日讯，近日，国家金融监督管理总局泰州监管分局发布了罚单，剑指和谐健康保险股份有限公司泰州中心支公司及其相关责任人。罚单显示，和谐健康保险股份有限公司泰州中心支公司的主要违法违规事实（案由）为：业务数据不真实、承诺给予或给予客户保险合同约定以外利益、财务数据不真实。针对上述违法违规行为，国家金融监督管理总局泰州监管分局对其罚款69万元；对和谐健康保险股份有限公司泰州中心支公司副总经理王擎警告并处罚款15万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1771068889721567457","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4581","XBI","XLV","BK4585","LABU","BK4588"],"gpt_icon":0},{"id":"2611192456","title":"創業慧康新註冊《創業醫療健康數據匯聚系統軟件V6》等2個項目的軟件著作權","url":"https://stock-news.laohu8.com/highlight/detail?id=2611192456","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611192456?lang=zh_tw&edition=fundamental","pubTime":"2026-02-14 09:34","pubTimestamp":1771032850,"startTime":"0","endTime":"0","summary":"证券之星消息，近日创业慧康新注册了2个项目的软件著作权，包括《创业医疗健康数据汇聚系统软件V6》、《创业医疗健康数据模型管理系统软件V6》等。今年以来创业慧康新注册软件著作权6个，较去年同期增加了20%。通过天眼查大数据分析，创业慧康科技股份有限公司共对外投资了61家企业，参与招投标项目8200次；财产线索方面有商标信息65条，专利信息123条，著作权信息780条；此外企业还拥有行政许可74个。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260214/32018863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300451","BK4581","LU0405327148.USD","BK4588","XBI","VGT","LABU","XLV","BK0231","BK0146","161022","159760","LU0405327494.USD","BK0114","BK4585"],"gpt_icon":0},{"id":"2610946007","title":"AMN醫療保健服務公司盤中異動 臨近收盤大幅下挫5.03%報19.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610946007?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 04:39","pubTimestamp":1770842399,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日04时39分，AMN医疗保健服务公司股票出现波动，股价快速跳水5.03%。截至发稿，该股报19.34美元/股，成交量66.875万股，换手率1.74%，振幅5.88%。AMN医疗保健服务公司股票所在的医疗设施行业中，整体涨幅为5.58%。AMN医疗保健服务公司公司简介：AMN Healthcare Services Inc 在美国提供医疗保健劳动力解决方案和人员配备服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021204400097a5d710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021204400097a5d710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XLV","XBI","BK4588","AMN","BK4581","BK4585","LABU","BK4196"],"gpt_icon":0},{"id":"2610955288","title":"Humana公布季度虧損擴大，預計2026年盈利將下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955288","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955288?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 22:29","pubTimestamp":1770820140,"startTime":"0","endTime":"0","summary":"Humana公司公布第四季度亏损扩大，原因是医疗成本持续上升，并表示由于其联邦医疗保险计划的质量评级下降，预计 2026 年盈利将大幅下滑。 该公司报告亏损 10.1 亿美元，合每股亏损 6.61 美元；去年同期亏损 8.62 亿美元，合每股亏损 5.76 美元。 Humana预计，2026 年个人联邦医疗保险优选计划会员数量将增长约 25%，“这得益于公司以客户为导向的福利策略带来的新增销售与留存率提升，以及客户服务模式的优化”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-11/doc-inhmnhqz7462659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4588","BK4585","LABU","BK4581","XBI"],"gpt_icon":0},{"id":"2610934545","title":"Healthcare Services第四季度EPS為0.44美元 高於預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2610934545","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610934545?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 20:01","pubTimestamp":1770811298,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4581","BK4585","XBI","HCAR","LABU","XLV"],"gpt_icon":0},{"id":"2610933683","title":"和諧健康保險泰安中支被罰16萬，涉編制虛假資料","url":"https://stock-news.laohu8.com/highlight/detail?id=2610933683","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610933683?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 17:54","pubTimestamp":1770803676,"startTime":"0","endTime":"0","summary":"蓝鲸新闻2月11日讯，近日，国家金融监督管理总局泰安监管分局发布了罚单，剑指和谐健康保险股份有限公司泰安中心支公司及其时任经理陈传美。罚单显示，和谐健康保险股份有限公司泰安中心支公司的主要违法违规事实为：编制虚假资料。针对这一行为，国家金融监督管理总局泰安监管分局对其罚款16万元；对时任和谐健康保险股份有限公司泰安中心支公司营业部经理陈传美，警告并处以1.5万元罚款。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770801258420902225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4581","BK4585","XBI","LABU","XLV","BK4588"],"gpt_icon":0},{"id":"1186140440","title":"醫療保健板塊動態：市場快訊解讀","url":"https://stock-news.laohu8.com/highlight/detail?id=1186140440","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186140440?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 17:23","pubTimestamp":1770801827,"startTime":"0","endTime":"0","summary":"0241 GMT——尽管哈塔勒加集团在第三财季业绩超预期，但其销售增长动能仍显不足，联昌国际证券分析师陈成荣在研究报告中指出。他表示，手套供应过剩局面预计将至少持续至2027年，供需才能重新平衡。陈成荣将哈塔勒加2026至2028财年的核心净利润预测分别上调126%、70%和41%，主要基于成本假设的下调。联昌国际将其目标价从1.18林吉特下调至1.00林吉特，维持持有评级。该股当前上涨2.2%，报0.94林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","BK4585","BK4581","LABU","XBI"],"gpt_icon":0},{"id":"2610937278","title":"AMN醫療保健服務公司盤中異動 下午盤股價大漲5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610937278?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 02:35","pubTimestamp":1770748555,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时35分，AMN医疗保健服务公司股票出现波动，股价大幅拉升5.27%。AMN医疗保健服务公司股票所在的医疗设施行业中，整体涨幅为0.31%。其相关个股中，Park Dental Partners, Inc.、Docgo Inc.、AMN医疗保健服务公司涨幅较大，Newgenivf Group Limited、Agilon Health, Inc.、P3 Health Partners Inc.较为活跃，换手率分别为19.38%、2.69%、2.62%，振幅较大的相关个股有The Oncology Institute Inc C/Wts 、Agilon Health, Inc.、P3 Health Partners Inc.，振幅分别为22.92%、16.71%、15.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102355597a5aed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102355597a5aed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","XLV","BK4585","BK4581","AMN","BK4196","LABU","XBI"],"gpt_icon":0},{"id":"2610007633","title":"貝萊德大中華區陸文傑：中國經濟2026將保持強勁增長，電力和醫療健康確定性更好","url":"https://stock-news.laohu8.com/highlight/detail?id=2610007633","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610007633?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 16:07","pubTimestamp":1770624436,"startTime":"0","endTime":"0","summary":"AI将迎来新一轮历史性建设浪潮","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3765312","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3765312","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"贝莱德大中华区陆文杰：中国经济2026将保持强劲增长，电力和医疗健康确定性更好","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KWEB","BLK","IE00BGHQF748.EUR","LU0157215616.USD","LU2430703251.USD","BK4567","IE00BGHQF631.EUR","BK4533","LU0320765489.SGD","IE00BVYPNW00.USD","LU0731783394.SGD","ASHR","LU0648001328.SGD","LU1599440770.SGD","LU0963586101.USD","LU0640476718.USD","IE00B3QW5Z07.USD","BK4135","LU1291159041.SGD","IE00BDGV0183.EUR","LU1074936037.SGD","HXC","LU1988902786.USD","BK4581","LU0980610538.SGD","IE00B3PB1722.GBP","LU2505996509.AUD","BK4535","MCHI","CWEB","IE00BVYPNV92.GBP","ASHS","LU0070302665.USD","LU1481011671.HKD","LU2505996681.GBP","CQQQ","LU2592432038.USD","IE00B42XCP33.USD","LABU","LU2430703178.SGD","LU1481011911.USD","XBI","LU1989771016.USD","BK4585","IE00B64PRP62.GBP","LU0742537680.HKD","LU1064131342.USD","BK4614","LU1366333091.USD","LU1201861249.SGD","LU0208291251.USD","LU0731783048.USD","LU2264538146.SGD","LU1670627923.USD","BK4588","BK4534","LU2430703095.HKD","DRAG","LU1280957306.USD","LU0772969993.USD","LU1509826696.USD","BK4504","LU0130102774.USD","LU1670628061.USD"],"gpt_icon":0},{"id":"2609504579","title":"【投孖展動態】安濟盛生物D輪孖展，孖展額1.3億美元，投資方為Frazier Life Sciences、Venrock Healthcare Capital Partners等","url":"https://stock-news.laohu8.com/highlight/detail?id=2609504579","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609504579?lang=zh_tw&edition=fundamental","pubTime":"2026-02-08 20:03","pubTimestamp":1770552185,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于2月4日公布的信息整理，安济盛生物医药技术(广州)有限公司D轮融资，融资额1.3亿美元，参与投资的机构包括Frazier Life Sciences，Venrock Healthcare Capital Partners，Ascenta Capital，BlackRock Innovation Capital，BVF，Logos Capital，RA Capital Management，威灵顿，Bain Capital Life Sciences，Elikon Venture，Janus Henderson，三正健康，高瓴资本，君联资本，晨兴创投，奥博资本，泰福资本，涌铧投资。安济盛生物医药技术(广州)有限公司成立于2018年6月,地处广州科学城，是一家专注于骨骼肌肉关节等疾病新药研发的跨国研发企业。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/08/20260208385613.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/08/20260208385613.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260208/32006199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4581","XBI","XLV","BK4585","HCCCU","LABU","BK4588"],"gpt_icon":0},{"id":"2609254915","title":"2026年度南昌市靈活就業人員繳納醫保指南出爐","url":"https://stock-news.laohu8.com/highlight/detail?id=2609254915","media":"南昌发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609254915?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 14:30","pubTimestamp":1770445800,"startTime":"0","endTime":"0","summary":"灵活就业人员自愿参加职工医保的，应当按年一次性缴纳全年费用，不允许按月缴费，待遇享受按有关规定执行。职工医保停保后转为以灵活就业人员身份参保的，可从停保次月一次性缴费至当年的12月31日。当年已参加居民医保并缴费的，不得中途再以灵活就业人员身份参加当年职工医保。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-02-07/doc-inhkykzi4247953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","XBI","XLV","BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2609459639","title":"一批製造公眾用藥焦慮，引導購買高端醫療保險的賬號被依法處置","url":"https://stock-news.laohu8.com/highlight/detail?id=2609459639","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609459639?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 20:23","pubTimestamp":1770380580,"startTime":"0","endTime":"0","summary":"来源：北京商报\n 2月6日，北京商报记者了解到，近期，中央网信办会同国家医保局深入整治涉医药集中带量采购的网上虚假不实信息，依法依约处置一批污名集采、制造焦虑、误导公众的账号。根据通报的典型案例，微博账号“成都XXX”，抖音账号“琼波XX”“亮晶晶的XX”等，歪曲国家政策，编造“进口药集体退出中国”等不实信息，煽动网民对原研药与仿制药的对立情绪，其中部分账号旨在制造公众用药焦虑，引导公众购买相关保健品、高端医疗保险，或诱导公众到特定的互联网平台购药。涉及的账号已被依法依约采取处置措施。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：曹睿潼","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-06/doc-inhkwssf2096736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4581","BK4588","BK4585","XLV","XBI"],"gpt_icon":0},{"id":"2609536060","title":"【券商聚焦】中信證券：商保有望成為醫療健康產業支付端的核心增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2609536060","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609536060?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 08:31","pubTimestamp":1770337883,"startTime":"0","endTime":"0","summary":"下一阶段，该机构认为商保综合服务提供商有望解决保司端人才、数据制约，打开创新药械企业创新价值兑现面临的结构性瓶颈，进一步助推商业健康险行业边际加速发展。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974659","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","600030","LU1064131003.USD","BK4581","LABU","159760","BK1564","BK4585","06030","BK0196","BK1521","LU2289578879.USD","BK0028","BK0183","LU1064130708.USD","LU0405327148.USD","LU1720050803.USD","BK0276","BK0012","BK4588","LU1655091616.SGD","LU2148510915.USD","LU1255011170.USD","BK1147","BK1516","LU2495084118.USD","LU1328615791.USD","LU1997245177.USD","XLV","LU1794554557.SGD","LU1997244956.HKD","XBI","LU1997245094.SGD","BK0188"],"gpt_icon":0},{"id":"1125439079","title":"醫療保健板塊動態：市場焦點解讀","url":"https://stock-news.laohu8.com/highlight/detail?id=1125439079","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125439079?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 05:52","pubTimestamp":1770328365,"startTime":"0","endTime":"0","summary":"最新一期医疗保健板块市场动态分析。Neuren公司表示，其合作伙伴Acadia Pharmaceuticals近期收到欧洲药品管理局关键委员会的通报，trofinetide的上市许可申请未获支持票。杰富瑞在报告中称：\"基于此消息并保持审慎态度，我们现预计trofinetide在欧盟销售的版权收益将于2026财年第四季度初实现。得益于影像类产品的强劲需求，这家德国医疗企业的市场份额持续扩大。分析师补充道，该公司始终是板块重点推荐标的。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","XBI","LABU","XLV","BK4588"],"gpt_icon":0},{"id":"2609651523","title":"Viemed Healthcare, Inc.盤中異動 股價大漲5.19%報8.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609651523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609651523?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 04:10","pubTimestamp":1770322215,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日04时10分，Viemed Healthcare, Inc.股票出现异动，股价急速拉升5.19%。Viemed Healthcare, Inc.股票所在的医疗器械行业中，整体涨幅为0.15%。其相关个股中，Trisalus Life Sciences Inc C/Wts 10/08/28 、Tenon Medical Inc C/Wts 16/06/2028 、Nexalin Technology, Inc.涨幅较大，Envue Medical, Inc.、Nexalin Technology, Inc.、Intelligent Bio Solutions Inc.较为活跃，换手率分别为221.64%、31.32%、18.00%，振幅较大的相关个股有Tela Bio, Inc.、Envue Medical, Inc.、Nuwellis, Inc.，振幅分别为60.01%、19.17%、18.27%。Viemed Healthcare, Inc.公司简介：Viemed Healthcare Inc 是一家为呼吸系统疾病、汲氧问题、睡眠呼吸暂停和 PAP 治疗患者提供医疗设备和家庭治疗的供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020604101595400892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020604101595400892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","XLV","VMD","BK4588","BK4585","LABU","BK4581","XBI"],"gpt_icon":0},{"id":"2609588416","title":"Healthcare Triangle, Inc.盤中異動跌6.40% 換手率達47.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609588416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609588416?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 23:34","pubTimestamp":1770305648,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日23时34分，Healthcare Triangle, Inc.股票出现波动，股价急速跳水6.40%。Healthcare Triangle, Inc.股票所在的健康信息服务行业中，整体跌幅为1.74%。Healthcare Triangle, Inc.公司简介：Healthcare Triangle Inc 是一家专注于推动行业变革解决方案的医疗信息技术公司，主要关注云服务、数据科学以及医疗和生命科学行业的专业与托管服务领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020523340897a510bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020523340897a510bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XBI","BK4581","HCTI","BK4167","BK4585","LABU","BK4588","XLV"],"gpt_icon":0},{"id":"2609737157","title":"瑞銀——美國醫療保健服務行業周度觀察（附下載）","url":"https://stock-news.laohu8.com/highlight/detail?id=2609737157","media":"外资精华观点","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609737157?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 15:42","pubTimestamp":1770277357,"startTime":"0","endTime":"0","summary":"免费体验“高时效”国际投行研报“T+0至T+1”“原研报”可至底部下载瑞银——美国医疗保健服务行业周度观察：医疗人员配置与急性期后护理板块表现突出，美国医疗支出增长，管理式医疗CEO将出席听证会精华翻译 板块表现分化：截至1月16日当周，医疗保健服务类股上涨0.6%，跑赢标普500指数及 broader医疗保健指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161612a47f4a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161612a47f4a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XLV","BK4137","XBI","BK4581","BK4585","LU0029874061.USD","HCSG","LABU","LU0128526141.USD","BK4588"],"gpt_icon":0},{"id":"2608362077","title":"復星醫藥：公司直接運營的業務覆蓋製藥、醫療器械及醫學診斷、醫療健康服務","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362077","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608362077?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 21:37","pubTimestamp":1770212245,"startTime":"0","endTime":"0","summary":"证券日报网讯2月4日，复星医药在互动平台回答投资者提问时表示，公司自1994年创立于上海，是一家植根中国、创新驱动的全球化医药健康产业集团。目前，公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务；其中，制药是公司的核心主营业务，也是公司品牌建设的重要承载。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602043641720167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09997","BK0183","BK4585","BK0028","BK1593","02196","159760","BK1222","BK1515","BK0175","BK0188","09996","BK0196","BK0096","159883","600196","BK1583","BK0060","BK1191","XBI","XLV","BK0187","LABU","BK0012","01477","BK4581","BK1100","BK0239","BK4588","BK1574"],"gpt_icon":0},{"id":"2608334357","title":"一線｜腦機接口商業化轉向：企業正加速從消費場景轉向醫療健康領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2608334357","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608334357?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 18:08","pubTimestamp":1770199680,"startTime":"0","endTime":"0","summary":"随着研发与产业化的推进，脑机接口的商业化重心正明显向医疗健康领域集中。脑机接口设备日趋便携化、小型化，并在国内完善产业链的支撑下走向大规模量产。脑机接口领域在蓬勃发展的表象之下，亦潜藏着根本性的战略分歧。脑机接口行业从业人员李飞告诉蓝鲸科技记者。当脑机接口决定认真“治病”近年来，脑机接口企业正加速从消费场景转向医疗健康领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770193931196031365","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","XLV","BK4585","LABU","BK4581","159760","XBI"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":142,"code":"91000000","status":"200"}]}}